copper gluconate has been researched along with rhenium in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bundesen, PG; Schmidt, PF; Smith, SV | 1 |
| Blok, D; Feitsma, RI; Giron, MC; Mazzi, U; Pauwels, EK; Rossin, R; Visentin, R | 1 |
| Archimandritis, SC; Bouziotis, P; Fragogeorgi, EA; Gourni, E; Livaniou, E; Loudos, G; Mavri-Vavayanni, M; Mitsokapas, N; Paravatou-Petsotas, M; Varvarigou, AD; Xanthopoulos, S; Zikos, C | 1 |
| Altai, M; Honarvar, H; Larsson, E; Löfblom, J; Lubberink, M; Orlova, A; Sandström, M; Ståhl, S; Strand, J; Strand, SE; Tolmachev, V; Varasteh, Z; Wållberg, H | 1 |
4 other study(ies) available for copper gluconate and rhenium
| Article | Year |
|---|---|
188Re DD-3B6/22 Fab' for use in therapy of ovarian cancer: labelling and animal studies.
Topics: Animals; Ascorbic Acid; Female; Gluconates; Immunoglobulin Fab Fragments; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Ovarian Neoplasms; Oxidation-Reduction; Radioimmunodetection; Radioisotopes; Radiopharmaceuticals; Radiotherapy; Rhenium; Technetium | 1998 |
99mTc-labeling experiments on CCK(4) by a direct method.
Topics: Borohydrides; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Diphosphates; Gluconates; Indicators and Reagents; Isotope Labeling; Radioisotopes; Rhenium; Technetium; Tetragastrin | 2001 |
Spacer site modifications for the improvement of the in vitro and in vivo binding properties of (99m)Tc-N(3)S-X-bombesin[2-14] derivatives.
Topics: Animals; Biological Transport; Bombesin; Cell Line, Tumor; Chromatography, Liquid; Female; Gluconates; Humans; Isotopes; Kidney; Liver; Male; Mice; Organotechnetium Compounds; Radiochemistry; Rhenium; Spectrometry, Mass, Electrospray Ionization | 2009 |
188Re-ZHER2:V2, a promising affibody-based targeting agent against HER2-expressing tumors: preclinical assessment.
Topics: Animals; Antibodies; Cell Line, Tumor; Chelating Agents; Drug Evaluation, Preclinical; Female; Gluconates; Humans; Mice; Mice, Nude; Oligopeptides; Ovarian Neoplasms; Peptides; Radiation Dosage; Radioisotopes; Radiometry; Radiopharmaceuticals; Receptor, ErbB-2; Rhenium; Xenograft Model Antitumor Assays | 2014 |